Anfield Capital Management, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Anfield Capital Management, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$30,145
+58.7%
2,433
+35.2%
0.02%
+66.7%
Q3 2022$19,000
-5.0%
1,799
+3.3%
0.01%0.0%
Q2 2022$20,000
+5.3%
1,741
+15.4%
0.01%
+28.6%
Q1 2022$19,000
+137.5%
1,509
+120.6%
0.01%
+133.3%
Q4 2021$8,000
+700.0%
684
+1241.2%
0.00%
Q3 2021$1,000510.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders